Tavapadon, Tavapadon, Tavapadon clinical trials

58-week Open-Label Trial of Tavapadon in Parkinson’s Disease (Tempo-4 Trial)

This study is looking at a new medication called Tavapadon for people with Parkinson's disease. Researchers want to see if it's safe and how well it helps with symptoms over 58 weeks. It's a Phase 3 trial, meaning it's a big step towards potentially becoming a new treatment.